This study is in progress, not accepting new patients
JSP191 Antibody Targeting Conditioning in SCID Patients
Summary
- Eligibility
- for people ages 3 months to 12 years (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Theodore B. Moore, M.D.
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Theodore B. Moore, M.D.
Professor of Clinical, Pediatrics, Medicine. Authored (or co-authored) 87 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Jasper Therapeutics, Inc.
- ID
- NCT02963064
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated